Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

SHA:600165 Revenue

Ningxia Zhongke Biotechnology had revenue of 156.72M CNY in the quarter ending June 30, 2026, with 28.70% growth. This brings the company's revenue in the last twelve months to 503.26M, up 12.48% year-over-year. In the year 2025, Ningxia Zhongke Biotechnology had annual revenue of 444.48M with 28.72% growth. That makes Ningxia Zhongke Biotechnology the 24,830th largest company in the world by revenue and 4,428th in China.

• Revenue (ttm): 503.26M
• Revenue Growth: +12.48%
• P/S Ratio: 10.85
• Revenue / Employee: 556.70K
• Employees: 904
• Market Cap: 5.46B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	444.48M	99.16M	28.72%
Dec 31, 2024	345.32M	59.63M	20.87%
Dec 31, 2023	285.69M	-395.44M	-58.06%
Dec 31, 2022	681.13M	432.42M	173.86%
Dec 31, 2021	248.72M	129.60M	108.80%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 9, 2026

Data Sources Report a data error